These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17220901)

  • 1. Bioinformatic discovery of novel bioactive peptides.
    Edwards RJ; Moran N; Devocelle M; Kiernan A; Meade G; Signac W; Foy M; Park SD; Dunne E; Kenny D; Shields DC
    Nat Chem Biol; 2007 Feb; 3(2):108-12. PubMed ID: 17220901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A shortcut to peptides to modulate platelets.
    Apic G; Russell RB
    Nat Chem Biol; 2007 Feb; 3(2):83-4. PubMed ID: 17235341
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A palmitoylated peptide, derived from the acidic carboxyl-terminal segment of the integrin alphaIIb cytoplasmic domain, inhibits platelet activation.
    Koloka V; Christofidou ED; Vaxevanelis S; Dimitriou AA; Tsikaris V; Tselepis AD; Panou-Pomonis E; Sakarellos-Daitsiotis M; Tsoukatos DC
    Platelets; 2008 Nov; 19(7):502-11. PubMed ID: 18979362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the role of adjacent amino acids to the 313-320 sequence of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
    Mitsios JV; Stamos G; Rodis FI; Tsironis LD; Stanica MR; Sakarellos C; Tsoukatos D; Tsikaris V; Tselepis AD
    Platelets; 2006 Aug; 17(5):277-82. PubMed ID: 16928597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel fibrinogen receptor antagonists. RGDF mimetics, derivatives of 4-(isoindoline-5-yl)amino-4-oxobutyric acid.
    Krysko AA; Chugunov BM; Malovichko OL; Andronati SA; Kabanova TA; Karaseva TL; Kiriyak AV
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5533-5. PubMed ID: 15482918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivatives of 7-amino-1,2,3,4-tetrahydroisoquinoline and isophthalic acids as novel fibrinogen receptor antagonists.
    Malovichko OL; Petrus AS; Krysko AA; Kabanova TA; Andronati SA; Karaseva TL; Kiriyak AV
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5294-7. PubMed ID: 16919941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular dichroism studies of type III collagen mimetic peptides with anti- or pro-aggregant activities on human platelets.
    Pêcher J; Pires V; Djaafri I; Da Nascimento S; Fauvel-Lafève F; Legrand C; Sonnet P
    Eur J Med Chem; 2009 Jun; 44(6):2643-50. PubMed ID: 19056149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of an orally active non-peptide fibrinogen receptor antagonist.
    Stilz HU; Jablonka B; Just M; Knolle J; Paulus EF; Zoller G
    J Med Chem; 1996 May; 39(11):2118-22. PubMed ID: 8667355
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICln, a novel integrin alphaIIbbeta3-associated protein, functionally regulates platelet activation.
    Larkin D; Murphy D; Reilly DF; Cahill M; Sattler E; Harriott P; Cahill DJ; Moran N
    J Biol Chem; 2004 Jun; 279(26):27286-93. PubMed ID: 15075326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced GPIIb/IIIa expression in platelets hyposensitive to catecholamines when activated with TRAP.
    Kim JM; Koo YK; Heo JE; Park S; Yun-Choi HS
    Thromb Res; 2009 May; 124(1):90-5. PubMed ID: 19232685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
    Madsen NJ; Holmes CE; Serrano FA; Sobel BE; Schneider DJ
    Am J Cardiol; 2007 Aug; 100(4):722-7. PubMed ID: 17697836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
    Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
    Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling.
    Marwali MR; Hu CP; Mohandas B; Dandapat A; Deonikar P; Chen J; Cawich I; Sawamura T; Kavdia M; Mehta JL
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1324-32. PubMed ID: 17538005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic integrin inhibition: allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies.
    Ahrens I; Peter K
    Thromb Haemost; 2008 May; 99(5):803-4. PubMed ID: 18449408
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet function testing and implications for clinical practice.
    Collet JP; Montalescot G
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species and human platelet GP IIb/IIIa receptor activation.
    Sill JC; Proper JA; Johnson ME; Uhl CB; Katusic ZS
    Platelets; 2007 Dec; 18(8):613-9. PubMed ID: 18041653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.